CamNtech is pleased to announce that the MotionWatch and PRO-Diary have been cleared by the US FDA to be legally marketed in the USA.
CamNtech is pleased to announce that the MotionWatch and PRO-Diary have been cleared by the US FDA to be legally marketed in the USA.
These products join the Actiheart and Actiwave devices to form a full suite of products that may be used for clinical or research applications in the USA.
The MotionWatch and PRO-Diary are US FDA class II devices and are grouped under product code LEL.
CamNtech are committed to providing professional solutions to clinicians and researchers around the world.